| Target Price | $32.64 |
| Price | $16.99 |
| Potential |
92.11%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Denali Therapeutics Inc. 2026 .
The average Denali Therapeutics Inc. target price is $32.64.
This is
92.11%
register free of charge
$42.00
147.20%
register free of charge
$24.24
42.67%
register free of charge
|
|
| A rating was issued by 24 analysts: 23 Analysts recommend Denali Therapeutics Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Denali Therapeutics Inc. stock has an average upside potential 2026 of
92.11%
register free of charge
|
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wedbush |
Locked
➜
Locked
|
Locked | Dec 11 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Dec 05 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Dec 05 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 18 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | May 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wedbush:
Locked
➜
Locked
|
Dec 11 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Dec 05 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Dec 05 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Sep 08 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 18 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
May 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


